Cross-reactive humoral immunity of clade 2 Oka and MAV/06 strain-based varicella vaccines against different clades of varicella–zoster virus

References

• Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974;2(7892):1–8. doi:10.1016/s0140-6736(74)90144-5. PMID: 4139526.
   PubMed Web of Science ®Google Scholar
• Hwang KK, Park SY, Kim SJ, Ryu YW, Kim KH. Restriction fragment length polymorphism analysis of varicella-zoster virus isolated in Korea. J Korean Soc Virol. 1991;21:201–10.
   Google Scholar
• Park SY, Hwang KK, Choi MK, Ryu YW, Paik SB, Kim KH. Propagation of varicella-zoster virus isolated in Korea. J Korean Soc Virol. 1991;21:1–9.
   Google Scholar
• Hwang KK, Chun BH, Park HS, Park SY, Kim KH, Moon HM. Marker test for attenuation of varicella-zoster viruses isolated in Korea. J Korean Soc Virol. 1992;22:105–9.
   Google Scholar
• Tyler SD, Peters GA, Grose C, Severini A, Gray MJ, Upton C, Tipples GA. Genomic cartography of varicella–zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences. Virology. 2007;359(2):447–58. doi:10.1016/j.virol.2006.09.037. PMID: 17069870.
   PubMed Web of Science ®Google Scholar
• Gomi Y, Sunamachi H, Mori Y, Nagaike K, Takahashi M, Yamanishi K. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol. 2002;76(22):11447–59. doi:10.1128/jvi.76.22.11447-11459.2002. PMID: 12388706.
   PubMed Web of Science ®Google Scholar
• Jeon JS, Won YH, Kim IK, Ahn JH, Shin OS, Kim JH, Lee CH. Analysis of single nucleotide polymorphism among varicella-zoster virus and identification of vaccine-specific sites. Virology. 2016;496:277–86. doi:10.1016/j.virol.2016.06.017. PMID: 27376245.
   PubMed Web of Science ®Google Scholar
• Ndumbe PM, Cradock-Watson J, Levinsky RJ. Natural and artificial immunity to varicella zoster virus. J Med Virol. 1988;25(2):171–8. doi:10.1002/jmv.1890250207. PMID: 2839610.
   PubMed Web of Science ®Google Scholar
• Kim Y, Hwang JY, Lee KM, Lee E, Park H. Cross-sectional study of varicella zoster virus immunity in healthy Korean children assessed by glycoprotein enzyme-linked immunosorbent assay and fluorescent antibody to membrane antigen test. Vaccines (Basel). 2021;9(5):492. doi:10.3390/vaccines9050492. PMID: 34065863.
   PubMed Web of Science ®Google Scholar
• Brunell PA, Novelli VM, Keller PM, Ellis RW. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response. J Infect Dis. 1987;156(3):430–5. doi:10.1093/infdis/156.3.430. PMID: 3039010.
   PubMed Web of Science ®Google Scholar
• Giller RH, Winistorfer S, Grose C. Immunogenicity of purified varicella zoster virus glycoproteins. Pediatr Res. 1987;21(4):312. doi:10.1203/00006450-198704010-00868.
   Web of Science ®Google Scholar
• Haumont M, Jurdan M, Kangro H, Jacquet A, Massaer M, Deleersnyder V, Garcia L, Bosseloir A, Bruck C, Bollen A, et al. Neutralizing antibody responses induced by varicella‐zoster virus gE and gB glycoproteins following infection, reactivation or immunization. J Med Virol. 1997;53:63–8. doi:10.1002/(sici)1096-9071(199709)53:1<63:aid-jmv11>3.0.co;2-y. PMID: 9298734.
   PubMed Web of Science ®Google Scholar
• Sullivan NL, Reuter-Monslow MA, Sei J, Durr E, Davis CW, Chang C, McCausland M, Wieland A, Krah D, Rouphael N, et al. Breadth and functionality of varicella-zoster virus glycoprotein-specific antibodies identified after Zostavax vaccination in humans. J Virol. 2018;92(14):e00269–18. doi:10.1128/JVI.00269-18. PMID: 29743372.
   PubMed Web of Science ®Google Scholar
• Breuer J, Schmid DS, Gershon AA. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella. J Infect Dis. 2008;197(Suppl 2):S147–51. doi:10.1086/529448. PMID: 18419389 .
   PubMed Web of Science ®Google Scholar
• Breuer J, Grose C, Norberg P, Tipples G, Schmid DS. A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24–25 July 2008. J Gen Virol. 2010;91(4):821–8. doi:10.1099/vir.0.017814-0. PMID: 20071486.
   PubMedGoogle Scholar
• Jensen NJ, Rivailler P, Tseng HF, Quinlivan ML, Radford K, Folster J, Harpaz R, LaRussa P, Jacobsen S, Scott Schmid D. Revisiting the genotyping scheme for varicella-zoster viruses based on whole-genome comparisons. J Gen Virol. 2017;98(6):1434–8. doi:10.1099/jgv.0.000772. PMID: 28613146.
   PubMed Web of Science ®Google Scholar
• Schmidt-Chanasit J, Sauerbrei A. Evolution and world-wide distribution of varicella–zoster virus clades. Infect Genet Evol. 2011;11(1):1–0. doi:10.1016/j.meegid.2010.08.014. PMID: 20817040.
   PubMed Web of Science ®Google Scholar
• Kim JI, Jung GS, Kim YY, Ji GY, Kim HS, Wang WD, Park HS, Park SY, Kim GH, Kwon SN, et al. Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax. Virol J. 2011;8(1):547. doi:10.1186/1743-422X-8-547. PMID: 22176950.
   PubMedGoogle Scholar
• Sauerbrei A, Stefanski J, Gruhn B, Wutzler P. Immune response of varicella vaccinees to different varicella-zoster virus genotypes. Vaccine. 2011;29(22):3873–7. doi:10.1016/j.vaccine.2011.03.054. PMID: 21459174.
   PubMed Web of Science ®Google Scholar
• Choi UY, Kim KH, Lee J, Eun BW, Kim DH, Ma SH, Kim CS, Lapphra K, Tangsathapornpong A, Kosalaraksa P, et al. Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: a multinational, multicenter, randomized, double-blinded, active-controlled phase III study. Vaccine. 2021;39(12):1758–64. doi:10.1016/j.vaccine.2021.02.013. PMID: 33627245.
   PubMed Web of Science ®Google Scholar
• Kim MH, Jeon JS, Kim IK, Park JS, Park H, Shin OS, Lee CH. Characterization and phylogenetic analysis of Varicella-zoster virus strains isolated from Korean patients. J Microbiol. 2017;55(8):665–72. doi:10.1007/s12275-017-7171-3. PMID: 28752294.
   PubMed Web of Science ®Google Scholar
• Zell R, Taudien S, Pfaff F, Wutzler P, Platzer M, Sauerbrei A. Sequencing of 21 varicella-zoster virus genomes reveals two novel genotypes and evidence of recombination. J Virol. 2012;86(3):1608–22. doi:10.1128/JVI.06233-11. PMID: 22130537.
   PubMed Web of Science ®Google Scholar
• Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol. 1993;10(3):512–26. doi:10.1093/oxfordjournals.molbev.a040023. PMID: 8336541.
   PubMed Web of Science ®Google Scholar
• Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35(6):1547–9. doi:10.1093/molbev/msy096. PMID: 29722887.
   PubMed Web of Science ®Google Scholar
• Shin D, Shin Y, Kim E, Nam H, Nan H, Lee J. Immunological characteristics of MAV/06 strain of varicella-zoster virus vaccine in an animal model. BMC Immunol. 2022;23(1):27. doi:10.1186/s12865-022-00503-6. PMID: 35658899.
   PubMed Web of Science ®Google Scholar
• Lee YH, Choe YJ, Lee J, Kim E, Lee JY, Hong K, Yoon Y, Kim Y-K. Global varicella vaccination programs. Clin Exp Pediatr. 2022;65(12):555–62. doi:10.3345/cep.2021.01564. PMID: 36457198.
   PubMedGoogle Scholar
• Marin M, Leung J, Anderson TC, Lopez AS. Monitoring varicella vaccine impact on varicella incidence in the United States: surveillance challenges and changing epidemiology, 1995–2019. J Infect Dis. 2022;226(Supplement_4):S392–9. doi:10.1093/infdis/jiac22. PMID: 36265855.
   PubMed Web of Science ®Google Scholar
• Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Human Vacc Immunother. 2019;15(3):645–57. doi:10.1080/21645515.2018.1546525. PMID: 30427766.
   PubMed Web of Science ®Google Scholar
• Service HIRA. Healthcare bigdata hub [Internet]. Wonju (Korea): Health Insurance Review & Assessment Service; 2022 [accessed 2021 Sep 30]. https://opendata.hira.or.kr/home.do.
   Google Scholar
• Hattori F, Miura H, Sugata K, Yoshikawa A, Ihira M, Yahata Y, Kamiya H, Tanaka-Taya K, Yoshikawa T. Evaluating the effectiveness of the universal immunization program against varicella in Japanese children. Vaccine. 2017;35(37):4936–41. doi:10.1016/j.vaccine.2017.07.090. PMID: 28784281.
   PubMed Web of Science ®Google Scholar
• Huang WC, Huang LM, Chang IS, Tsai FY, Chang LY. Varicella breakthrough infection and vaccine effectiveness in Taiwan. Vaccine. 2011;29(15):2756–60. doi:10.1016/j.vaccine.2011.01.092. PMID: 21315697.
   PubMed Web of Science ®Google Scholar